Provided by Tiger Trade Technology Pte. Ltd.

Information

5.70
-0.0400-0.70%
Post-market: 5.700.00000.00%19:30 EDT
Volume:212.31K
Turnover:1.21M
Market Cap:275.96M
PE:23.76
High:5.80
Open:5.77
Low:5.63
Close:5.74
52wk High:6.45
52wk Low:3.74
Shares:48.41M
Float Shares:35.55M
Volume Ratio:0.59
T/O Rate:0.60%
Dividend:0.18
Dividend Rate:3.16%
EPS(TTM):0.2399
EPS(LYR):0.1900
ROE:12.30%
ROA:6.36%
PB:2.88
PE(LYR):30.00

Loading ...

Chanjet Information Technology Posts Strong Interim Results and Proposes Higher Dividend

TIPRANKS
·
Aug 19

Focus Media Information Technology's Attributable Profit Rises 17% in H1

MT Newswires Live
·
Aug 19

East Money Information Issues 2.6 Billion Yuan Bonds in Two Tranches

MT Newswires Live
·
Aug 19

ASX Midday Sector Update: Healthcare Stocks Jump, Information Technology Sector Struggles

MT Newswires Live
·
Aug 19

Press Release: EQB Inc. Releases an Abridged Supplemental Financial Information Package for Third Quarter 2026 Results

Dow Jones
·
Aug 19

Texas Ventures III Board Reappoints Glabe to Audit Chair

TIPRANKS
·
Aug 19

Osprey Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 21, 2026

GlobeNewswire
·
Aug 19

Press Release: Progress Software Appoints Bridget Collins as Chief Information Officer

Dow Jones
·
Aug 18

BSE Appoints Joint Chief Information Security Officer

MT Newswires Live
·
Aug 18

Transcend Information Fined NT$1.6 Million Over Trade Act Violation

MT Newswires Live
·
Aug 18

ISG to Host AI Impact Summit London on Autonomous Enterprise Strategies

Reuters
·
Aug 18

ISG: Swiss Enterprises Step up Microsoft AI Governance as Adoption Expands

Reuters
·
Aug 18

Sinomach's Related Company Fined for Information Inaccuracies

MT Newswires Live
·
Aug 18

Escalating Middle East Conflict Sparks Base Oil Price Surge, Automakers Accelerate Shift to Alternative Lubricant Formulations

Stock News
·
Aug 18

InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China

GlobeNewswire
·
Aug 18

Brazilian Rare Earths Withdraws Brazil Project Production Target, Forecasted Financial Information

MT Newswires Live
·
Aug 18

PicPay Transforms How Customers Access Their Financial Information Through Integration with ChatGPT

GlobeNewswire
·
Aug 18

HUTCHMED Surges Nearly 4% on Positive Late-Stage Trial Results for Combination Therapy

Stock News
·
Aug 17

AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial

TIPRANKS
·
Aug 17

Breakthrough: AstraZeneca and Daiichi Sankyo's ADC Shows Strong Efficacy in First-Line Lung Cancer Therapy

Stock News
·
Aug 17